/EINPresswire.com/ -- TORONTO, ONTARIO -- (Marketwired) -- 10/22/15 -- Supreme Pharmaceuticals Inc. (the "Company") (OTC PINK: SPRWF)(CSE: SL) advises that it has settled outstanding debts by the issuance of 215,000 common shares at a weighted average price of $0.125 per share. These shares shall be subject to a 4 month trading restriction.

About Supreme

Supreme is a Canadian publically traded company committed to becoming a leading supplier of affordable medical cannabis achieved by applying commercial agriculture practices to medical cannabis production. Supreme's flagship facility is a 342,000 sq. ft. hybrid greenhouse located in Kincardine, Ontario, which has been designed to maximize production efficiencies allowing the Company to pass savings along to its future patients.

Contacts:
Supreme Pharmaceuticals Inc.
Investor Relations
(416) 630-7272
info@supreme.ca
www.supreme.ca

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.